This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
ATH Technologies (E)
Simons, Robert L.; Packard, JenniferCase HBS-117017-EStrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
Merck: Managing Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-109084-EStarting at €5.74
-
ATH Technologies (E) (Spanish version)
Simons, Robert L.; Packard, JenniferCase HBS-118S07StrategySupplements the (A) case. Designed as an in-class handout.Starting at €5.74
-
Merck: La administración de Vioxx (E)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S06Knowledge and CommunicationStarting at €5.74
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20
-
Managing Risk in the New World
Kaplan, Robert S.; Mikes, Anette; Simons, Robert L.; Tufano, Peter; Hofmann, Michael; Champion, DavidArticle HBS-R0910E-EFive experts gathered recently to discuss the future of enterprise risk management: Kaplan, the Baker Foundation Professor at Harvard Business School, who with his colleague David Norton developed the balanced scorecard; Mikes, an assistant professor at HBS who studies the evolution of risk management and the role of the chief risk officer; Simons, the Charles M. Williams Professor of Business Administration at HBS; Tufano, the Sylvan C . Coleman...Starting at €8.20
-
C3.ai-Driven to Succeed
Simons, Robert L.; Gonzalez, GeorgeCase HBS-119004-EStrategyCEO Tom Siebel navigates his artificial intelligence (ai) startup through a series of pivots, market expansions, and even an elephant attack to become a leading platform ad service provider. The case describes his unusual management approach emphasizing eStarting at €8.20
-
Las alianzas entre empresas
Canals, JordiTechnical Note ASEN-177EconomicsSe presenta una introducción a los conceptos y algunos problemas que plantean las alianzas entre empresas, sus ventajas e inconvenientes, y algunos aspectos de su puesta en marcha.Starting at €8.20
-
Unilever (2017): el Consejo de Administración y el CEO en el gobierno corporativo y la estrategia
Canals, JordiCase SM-1671Corporate GovernanceEste caso enumera algunos de los desafíos que afrontan el Consejo de Administración de Unilever y su CEO, Paul Polman, en marzo del 2017. El contexto de la empresa incluye cambios en el comportamiento del consumidor, volatilidad e intentos fallidos de compra por parte de Kraft Heinz.Starting at €8.20
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S02Strategy(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Starting at €8.20